PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5594
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence ; day:23 ; month:5 ; year:2018 ; pages:1-13
Oncogene ; (23.5.2018), 1-13
- Urheber
-
Klein, Mary E.
- Beteiligte Personen und Organisationen
-
Dickson, Mark A.
Antonescu, Cristina
Qin, Li-Xuan
Dooley, Scott J.
Barlas, Afsar
Manova, Katia
Schwartz, Gary K.
Crago, Aimee M.
Singer, Samuel
Koff, Andrew
Tap, William D.
SpringerLink (Online service)
- DOI
-
10.1038/s41388-018-0332-y
- URN
-
urn:nbn:de:101:1-2018080123075190451598
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klein, Mary E.
- Dickson, Mark A.
- Antonescu, Cristina
- Qin, Li-Xuan
- Dooley, Scott J.
- Barlas, Afsar
- Manova, Katia
- Schwartz, Gary K.
- Crago, Aimee M.
- Singer, Samuel
- Koff, Andrew
- Tap, William D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Overdiagnosis of atypical lipomatous tumors/well-differentiated liposarcomas by morphological diagnosis using only HE stained specimens: a case–control study with MDM2/CDK4 immunostaining and MDM2/CDK4 fluorescence in situ hybridization
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma
Molecular pathways of senescence regulate placental structure and function
Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
Low-Grade Uterine Adenosarcoma with Overexpression of MDM2 and CDK4 by Immunohistochemistry: A Case Report and Literature Review
Mdm2 requires Sprouty4 to regulate focal adhesion formation and metastasis independent of p53
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
Npl3 stabilizes R-loops at telomeres to regulate replicative senescence
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Overdiagnosis of atypical lipomatous tumors/well-differentiated liposarcomas by morphological diagnosis using only HE stained specimens: a case–control study with MDM2/CDK4 immunostaining and MDM2/CDK4 fluorescence in situ hybridization
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma
Molecular pathways of senescence regulate placental structure and function
Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
Low-Grade Uterine Adenosarcoma with Overexpression of MDM2 and CDK4 by Immunohistochemistry: A Case Report and Literature Review
Mdm2 requires Sprouty4 to regulate focal adhesion formation and metastasis independent of p53
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
Npl3 stabilizes R-loops at telomeres to regulate replicative senescence
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Overdiagnosis of atypical lipomatous tumors/well-differentiated liposarcomas by morphological diagnosis using only HE stained specimens: a case–control study with MDM2/CDK4 immunostaining and MDM2/CDK4 fluorescence in situ hybridization
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma
Molecular pathways of senescence regulate placental structure and function
Regulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
Low-Grade Uterine Adenosarcoma with Overexpression of MDM2 and CDK4 by Immunohistochemistry: A Case Report and Literature Review
Mdm2 requires Sprouty4 to regulate focal adhesion formation and metastasis independent of p53
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors